Thrombolysis with plasminogen activators: use and research of serine proteinases, promise and actuality

   


1. Institute of Experimental Cardiology, Russian Cardiology Research-and-Production Complex
Type:
DOI: 10.18097/PBMC20146006677      UDK: 615.355:357.52      PubMed Id: 25552508
Year: 2014 vol: 60  issue:6  pages: 677-682
Abstract: Physiological plasminogen activators of tissue and urokinase type (serine proteinases) are effective thrombolytic agents. Research and development of their novel forms contributed to progress of thrombolytic therapy, advanced treatment of acute coronary syndrome and a marked decrease in the lethal index.
Download PDF:
Reference: Maksimenko A.V., Thrombolysis with plasminogen activators: use and research of serine proteinases, promise and actuality, Biomeditsinskaya khimiya, 2014, vol: 60(6), 677-682.
Bibliography
 2016(Vol:62)
 2015(Vol:61)
 2014(Vol:60)
 2013(Vol:59)
 2012(Vol:58)
 2011(Vol:57)
 2010(Vol:56)
 2009(Vol:55)
 2008(Vol:54)
 2007(Vol:53)
 2006(Vol:52)
 2005(Vol:51)
 2004(Vol:50)
 2003(Vol:49)